Print   

Monday 13 October, 2008

NextGen Group PLC

Placing

RNS Number : 7144F
NextGen Group PLC
13 October 2008
 



NextGen Group Plc


('NextGen' or 'the Company')


Placing


NextGen is pleased to announce that it has placed 210,000,000 ordinary shares of £0.001 each (the 'Placing Shares') with two existing shareholders of the Company (the 'Placing'). The Placing Shares are to be issued at £0.0015 per share to raise £315,000 before expenses of the Placing, in order to provide development funding and general working capital for the Company. In addition, for every 3 Placing Shares issued pursuant to the Placing, the Company will grant a warrant over 1 ordinary share of £0.001 each (the 'Ordinary Shares') with an exercise price of £0.0015 per share. Accordingly, warrants over 70,000,000 Ordinary Shares will be granted in the placing. The warrants shall be exercisable for 3 years from the date of grant.


The two subscribing shareholders are Perfekt Beteiligungsmanagement GmbH ('Perfekt) and Family Trust Select - FIS - Teilfonds Zeus ('Zeus') and the details of the subscription are as follows:



Number of Ordinary Shares held before Placing

Number of Placing Shares

Number of Warrants granted

Perfekt

154,937,806

124,833,000

41,611,000

Zeus

775,000,000

85,167,000

28,389,000


Following the Placing, the Company will have in issue 2,120,978,644 Ordinary Shares. The shareholdings of Perfekt and Fortis following the Placing are as follows:



Number of Ordinary Shares held

% of issued Ordinary Share Capital

Perfekt

279,770,806

13.19%

Zeus

860,167,000

40.55%



The Placing Shares will represent 9.9 per cent of the enlarged issued share capital immediately following the issue of the Placing Shares and will rank pari passu in all respects with the existing Ordinary Shares.


Application will be made for the Placing Shares to be admitted to trading on the AIM market of the London Stock Exchange. Dealings in the new shares are expected to commence on 17 October 2008.



For further details please contact:


Dr Michael Pisano

CEO, Nextgen Group PLC                01480 410 850


Jonathan Wright / Nicola Marrin

Seymour Pierce Limited                    020 7107 8000 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEILFLVIALVLIT

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.